Infinata’s BioPharm Insight Releases its Catalyst Monitor for March…

Key catalysts include US approval decisions for Zogenix, Biogen Idec, and Johnson & Johnson.

(PRWeb February 26, 2013)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.